FindTrial
Sign In

Quantitative Analysis of SPECT/CT Bone Imaging in the Diagnosis and Treatment of SAPHO Syndrome

Quantitative Analysis of SPECT/CT Bone Imaging in the Diagnosis and Treatment of SAPHO Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101754
Enrollment
Unknown
Registered
2025-04-29
Start date
2023-05-12
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SAPHO(Synovitis,acne,pustulosis,hyperostosis,and osteitis,SAPHO)

Interventions

Gold Standard:Whole-body bone scintigraphy enables systematic evaluation of osteoarticular lesions in SAPHO syndrome
Index test:(erythrocyte sedimentation rate,ESR),(C-reactive protein,CRP),SUVmax

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Adults (aged 18-85 years) who come for whole-body bone scintigraphy with suspected SAPHO syndrome.

Exclusion criteria

Exclusion criteria: Patients over 85 years of age, with limited mobility, who cannot adhere to the completion of the examination.

Design outcomes

Primary

MeasureTime frame
SUVmax;—

Countries

China

Contacts

Public ContactLu Yu

The First Affiliated Hospital of Harbin Medical University

luyu1117@hotmail.com+86 451 8555 5564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026